09969.HK
InnoCare Pharma Limited
HKSE · Healthcare · Biotechnology · CN
HKD 15.37
+4.06%Margins
Gross margin
89.9%
EBITDA margin
31.3%
EBIT margin
25.9%
Net margin
32.9%
FCF margin
8.6%
11.8%
Return on equity
8.1%
Return on assets
7.2%
Return on invested capital
0.26x
Asset turnover
HKD 373.7M
Cash from operations
HKD 5.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026